Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Neuland Laboratories has informed that it enclosed the presentation to the Investors/ Analysts on the Financial Results of the Company for the quarter ended June 30, 2024. The presentation is also being uploaded on the website of the Company at www.neulandlabs.com.
The above information is a part of company’s filings submitted to BSE.